[Follow-up after radiotherapy of anal canal carcinoma].

Fiche publication


Date publication

octobre 2015

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier


Tous les auteurs :
Meillan N, Huguet F, Peiffert D

Résumé

Anal canal carcinoma is a rare and curable disease for which the standard of care is radiation therapy with concurrent 5-fluoro-uracil and mitomycine-based chemotherapy. Post-treatment follow-up however is rather poorly defined. This article offers a review of the various post-treatment surveillance options both for early diagnosis of relapse and care for late treatment effects. While follow-up remains mostly clinical, we will discuss morphologic (endorectal echoendoscopy, pelvic magnetic resonance imaging, tomodensitometry and positron emission tomography) and biologic (squamous cell carcinoma antigen and pathology) follow-up so as to determine their diagnostic and prognostic value.

Mots clés

Anus Neoplasms, radiotherapy, Decision Trees, Follow-Up Studies, Humans

Référence

Cancer Radiother. 2015 Oct;19(6-7):610-5